Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease
Taimur Dad(Tufts Medical Center), Ronald D. Perrone(Tufts Medical Center), Godela Brosnahan(University of Colorado Denver), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Diane Comer(University of Pittsburgh), Frederic F. Rahbari-Oskoui(Emory University), Dana C. Miskulin(Tufts University), Vicente E. Torres(Mayo Clinic in Arizona), Michael F. Flessner, Theodore I. Steinman(Beth Israel Deaconess Medical Center), Marie C. Hogan(Mayo Clinic), William E. Braun(Cleveland Clinic), Cheng Tao(University of Pittsburgh Medical Center), Diana Kaya(The University of Texas MD Anderson Cancer Center), Charity G. Moore(University of Pittsburgh Medical Center), Robert W. Schrier(University of Denver), K.T. Bae(University of Pittsburgh), Kaleab Z. Abebe(University of Pittsburgh), Arlene B. Chapman(Emory University), Franz T. Winklhofer(University of Kansas)
Cited by 9
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia
|New England Journal of Medicine|2006|1.2k
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2015|602
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy
|Kidney International|1998|535